112 related articles for article (PubMed ID: 11745365)
1. CD19(+) cells produce IFN-gamma in mice infected with Borrelia burgdorferi.
Ganapamo F; Dennis VA; Philipp MT
Eur J Immunol; 2001 Dec; 31(12):3460-8. PubMed ID: 11745365
[TBL] [Abstract][Full Text] [Related]
2. Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi.
Ganapamo F; Dennis VA; Philipp MT
Infect Immun; 2000 Dec; 68(12):7162-5. PubMed ID: 11083848
[TBL] [Abstract][Full Text] [Related]
3. Differential acquired immune responsiveness to bacterial lipoproteins in Lyme disease-resistant and -susceptible mouse strains.
Ganapamo F; Dennis VA; Philipp MT
Eur J Immunol; 2003 Jul; 33(7):1934-40. PubMed ID: 12884859
[TBL] [Abstract][Full Text] [Related]
4. Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice.
Zeidner N; Mbow ML; Dolan M; Massung R; Baca E; Piesman J
Infect Immun; 1997 Aug; 65(8):3100-6. PubMed ID: 9234760
[TBL] [Abstract][Full Text] [Related]
5. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis suppresses IL-2 and IFN gamma production and promotes an IL-4 response in C3H/HeJ mice.
Zeidner NS; Dolan MC; Massung R; Piesman J; Fish D
Parasite Immunol; 2000 Nov; 22(11):581-8. PubMed ID: 11116438
[TBL] [Abstract][Full Text] [Related]
6. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.
Keane-Myers A; Nickell SP
J Immunol; 1995 Aug; 155(4):2020-8. PubMed ID: 7636253
[TBL] [Abstract][Full Text] [Related]
7. Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.
Munson EL; Du Chateau BK; Jensen JR; Callister SM; DeCoster DJ; Schell RF
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1095-101. PubMed ID: 12204965
[TBL] [Abstract][Full Text] [Related]
8. Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.
Keane-Myers A; Maliszewski CR; Finkelman FD; Nickell SP
J Immunol; 1996 Apr; 156(7):2488-94. PubMed ID: 8786309
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.
Munson EL; DeCoster DJ; Nardelli DT; England DM; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2004 Jan; 11(1):35-41. PubMed ID: 14715542
[TBL] [Abstract][Full Text] [Related]
10. Control of Borrelia burgdorferi-specific CD4+-T-cell effector function by interleukin-12- and T-cell receptor-induced p38 mitogen-activated protein kinase activity.
Hedrick MN; Olson CM; Conze DB; Bates TC; Rincón M; Anguita J
Infect Immun; 2006 Oct; 74(10):5713-7. PubMed ID: 16988247
[TBL] [Abstract][Full Text] [Related]
11. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection.
Pohl-Koppe A; Balashov KE; Steere AC; Logigian EL; Hafler DA
J Immunol; 1998 Feb; 160(4):1804-10. PubMed ID: 9469440
[TBL] [Abstract][Full Text] [Related]
12. Effect of anti-interleukin 12 treatment on murine lyme borreliosis.
Anguita J; Persing DH; Rincon M; Barthold SW; Fikrig E
J Clin Invest; 1996 Feb; 97(4):1028-34. PubMed ID: 8613525
[TBL] [Abstract][Full Text] [Related]
13. Analysis of cytokine patterns produced by individual CD4+ lymph node cells during experimental murine leishmaniasis in resistant and susceptible mice.
Sommer F; Meixner M; Mannherz M; Ogilvie AL; Röllinghoff M; Lohoff M
Int Immunol; 1998 Dec; 10(12):1853-61. PubMed ID: 9885906
[TBL] [Abstract][Full Text] [Related]
14. Cytokines (IL-4 and IFN-gamma) and antibodies (IgE and IgG2a) produced in mice infected with Borrelia burgdorferi sensu stricto via nymphs of Ixodes ricinus ticks or syringe inoculations.
Christe M; Rutti B; Brossard M
Parasitol Res; 2000 Jun; 86(6):491-6. PubMed ID: 10894476
[TBL] [Abstract][Full Text] [Related]
15. Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon.
Brown CR; Reiner SL
Infect Immun; 1999 Jul; 67(7):3329-33. PubMed ID: 10377109
[TBL] [Abstract][Full Text] [Related]
16. Gamma interferon is not required for arthritis resistance in the murine Lyme disease model.
Glickstein L; Edelstein M; Dong JZ
Infect Immun; 2001 Jun; 69(6):3737-43. PubMed ID: 11349038
[TBL] [Abstract][Full Text] [Related]
17. Arthritis is developed in Borrelia-primed and -infected mice deficient of interleukin-17.
Kuo J; Warner TF; Munson EL; Nardelli DT; Schell RF
Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27493062
[TBL] [Abstract][Full Text] [Related]
18. Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-γ-mediated Lyme arthritis.
Sonderegger FL; Ma Y; Maylor-Hagan H; Brewster J; Huang X; Spangrude GJ; Zachary JF; Weis JH; Weis JJ
J Immunol; 2012 Feb; 188(3):1381-93. PubMed ID: 22180617
[TBL] [Abstract][Full Text] [Related]
19. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.
Nardelli DT; Burchill MA; England DM; Torrealba J; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1075-84. PubMed ID: 15539509
[TBL] [Abstract][Full Text] [Related]
20. Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.
Yang L; Ma Y; Schoenfeld R; Griffiths M; Eichwald E; Araneo B; Weis JJ
Infect Immun; 1992 Aug; 60(8):3033-41. PubMed ID: 1639470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
